Largest Biotech Companies In Massachusetts

Largest Biotech Companies In Massachusetts
Largest Biotech Companies In Massachusetts Image link: https://en.wikipedia.org/wiki/List_of_U.S._states_and_territories_by_area
C O N T E N T S:

KEY TOPICS

  • Massachusetts attracts some of the largest pharma and biotech companies, driving employment and investment to the area.(More…)
  • The Massachusetts Biotechnology Council on Wednesday released its annual Industry Snapshot, which tallied a total of $3.1 billion in venture investments in biopharma companies here in 2017, and another $2.7 billion raised by Massachusetts biopharma companies in the first half of 2018.(More…)
  • According to author Carol Milano, each year the magazine conducts its Science Careers Top Employers Survey to find the 20 companies with the best reputations in the industry, “as well as the characteristics that most impact an employer?s status.”(More…)
  • Some manufacturing companies here in western Massachusetts are looking for workers.To fill those jobs at several small companies, CareerPoint in Holyoke conducts frequent job fairs.(More…)

POSSIBLY USEFUL

  • It is a similar story this year so far, as the non-profit organisation Massachusetts Biotechnology Council (MassBio) revealed that biotechs in the area account for 40% of all IPOs.(More…)

RANKED SELECTED SOURCES

Double click on a snippet to show in context, i.e. with its surrounding text Modes 1) double click snippet to see in context; 2) double click snippet to Share or Publish

KEY TOPICS

Massachusetts attracts some of the largest pharma and biotech companies, driving employment and investment to the area. [1] Massachusetts companies accounted for 48 percent of all initial public offerings by U.S.-based biotech companies in 2017, the report said, and the 15 Massachusetts IPOs so far in 2017 account for nearly 40 percent of all U.S.-based biotech IPOs. [2]

Almost half of all U.S. biotech investment is made in these areas, about one-third of the biotechnology employees work for companies in these areas, and about a quarter of U.S. biotech companies are located in one of these clusters. [3] Including the roughly 3,500 employees at MIT’s Lincoln Labs, which does work in many different fields in addition to biotechnology, 15,298 people work at biotech companies in Lexington. [2]

On the eve of Boston Biotech Week, a report was released by MassBio that claimed 48% of all biotech investment in 2017 was accounted for by Massachusetts-based companies. [1] Join MassBio MassBio members join an unparalleled network of innovative companies and industry thought leaders with access to opportunities for visibility, professional development and growth. [4] In total, companies in the biopharma industry employ close to 70,000 individuals. [1] Based on a PricewaterhouseCoopers/CB Insights HealthCare MoneyTree Report, in second quarter 2018 approximately $1.65 billion was invested in Silicon Valley area health care companies. [3] Events Calendar Join MassBio and our member companies at upcoming life sciences events. [4] Blog Read about the people, companies and issues driving the life sciences. [4]

The Massachusetts Biotechnology Council on Wednesday released its annual Industry Snapshot, which tallied a total of $3.1 billion in venture investments in biopharma companies here in 2017, and another $2.7 billion raised by Massachusetts biopharma companies in the first half of 2018. [2] More encouraging, according to MassBio, was that nearly half of the 12 Massachusetts IPOs completed in 2017 were carried out by companies based outside the Boston/Cambridge, MA, region, in suburbs such as Waltham, Newton, and Burlington. [5] More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby communities like Lexington, according to a new industry report. [2]

Cambridge-based companies received 62 percent, or $1.8 billion, of all biotech venture investment in the state, with companies in Boston ($320 million), Waltham ($242 million), Lexington ($129 million) and Woburn ($97 million) accounting for a significant portion of the rest, the report said. [2] Cambridge has little — if any — room left for new labs, and developers have begun proposing and building new developments meant to attract biotech and pharmaceutical companies in parts of Boston, including the Seaport District. [6] According to statistics from the town of Lexington’s Economic Development Office, Lexington has 32 companies operating in the biotech field. [2]

That dominance has continued into this year, with 15 Massachusetts-based companies issuing their first public stock 2018 this year–nearly 40% all U.S.-based biotech IPOs issued during the first half of 2018. [5] Crossing the Data Desert: A How to for Pre-Commercial Biotech IPOs – For pre-commercial life science companies, clinical trial data is king. [7]

According to the report, job data comes from both the U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW), and data from privately owned companies. [5] The 12 companies that went public in 2016 were concentrated geographically in a similar way as the venture investments, with six located in Cambridge, three in Waltham and one each in Boston, Newton and Burlington. [2]

According to author Carol Milano, each year the magazine conducts its Science Careers Top Employers Survey to find the 20 companies with the best reputations in the industry, “as well as the characteristics that most impact an employer?s status.” [8]

How would you like to make your car run on oil leftover from making french fries? How about discovering new drugs that can combat cancer? Bay area Biotech-pharma Statistics Workshop (BBSW) Bay area Biotech-pharma Statistics Workshop (BBSW) Mon, Nov 5, 8:00am. favorite Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news. [9] This is the new Bay Area home of Illumina, the biotech behemoth that has almost single-handedly driven forward the genetic revolution in science and medicine Novato is the affordable alternative to other locations for North Bay biotech companies and the North Bay Life Science Alliance (NBLSA) is here to provide support. [9] Its customers include top-10 global pharmaceutical and biotech companies, small biotech companies, and academic institutions worldwide. [10]

Some manufacturing companies here in western Massachusetts are looking for workers.To fill those jobs at several small companies, CareerPoint in Holyoke conducts frequent job fairs. [11] The CRRC MA rail-car manufacturing facility at the former Westinghouse site was honored as the state’s outstanding engineering achievement of the year by the American Council of Engineering Companies of Massachusetts. [11] To be eligible, companies must be manufacturing companies based in Massachusetts and must meet the criteria used by the Commonwealth of Massachusetts to define a manufacturing corporation. [11] Below we will take a look at the most common business loan options available to Massachusetts firms, and compare them so that Bay State companies can make an informed-choice about what will best meet their needs. [12] Massachusetts is additionally recognized as the 25 th best state in the nation for business as they continue to produce new and traditional companies that play a crucial role in the state’s economy. [12] Eighteen companies from across the state have been selected as finalists for the 2018 Team Massachusetts Economic Impact Awards, MassEcon’s 15th annual celebration of firms for their outstanding contributions to the Massachusetts economy. [11] SBA loans are similar to bank term loan in that they are a very affordable type of small business financing for Massachusetts companies. [12] Alternative business loans or a fine financing option for Massachusetts companies that have good credit and good revenue but have been on able to get for approved for conventional or SBA financing from traditional lenders. [12]

The MIT Tech Review magazine’s 2017 list of 50 Smartest Companies, released Tuesday, names five companies from Massachusetts. [11]

U.S. manufacturing companies are expected to face a shortage of two million skilled workers by the year 2020. [11] American companies are even bringing their jobs back from abroad, according to the national Reshoring Initiative, an organization promoting manufacturing jobs in America. [11] It is an American multinational biotechnology product development company ranking as one of the leading companies in the genetic testing and precision laboratory equipment markets. [12] Those numbers are boosted by one company, the powerhouse Amgen (NASDAQ: AMGN ), which is among the nation’s top 10 most valuable public life-science companies. [13] It is also home to twelve Fortune 500 companies and is one of the top states for business and innovation. [12] U.S. Bedding Inc. has made Fortune’s 2017 Inner City 100, a list of the fastest growing inner city companies in the United States. [11] BOSTON — Three Fall River companies were honored at the Statehouse as a 2017 Manufacturer of the Year. [11]

POSSIBLY USEFUL

It is a similar story this year so far, as the non-profit organisation Massachusetts Biotechnology Council (MassBio) revealed that biotechs in the area account for 40% of all IPOs. [1] View All 2018 MassBio Industry Snapshot September 13, 2018 White Papers MassBio’s annual Industry Snapshot shows that Massachusetts biotechs dominated the IPO market in 2017. [4] MassBio’s annual Industry Snapshot shows that Massachusetts biotechs dominated the IPO market in 2017, accounting for nearly half of all US-based biotech IPOs (48%), up from 30% in 2016. 2018 has already outpaced 2017 in terms of total Massachusetts IPOs at 15, which accounts for nearly 40% of all US-based biotech IPOs (January – July 2018). [14]

There is a disparity between pharmaceutical-focused Massachusetts and the broader biotech segment in California. [3]

There were 1,896 new potential drugs in development or trials mentioned in the Massachusetts Biotechnology Council 2017 Industry snapshot versus the 1,274 medicines in the pipeline cited in the California Life Sciences Industry 2018 report for the entire state, not just the San Francisco Bay region. [3] According to the Massachusetts Biotechnology Education Foundation, in 2017 the number of life sciences industry jobs in Massachusetts surpassed 70,000 for the first time ever. [3] View All Statement by MassBio President & CEO Robert K. Coughlin on CHIA 2018 Annual Report September 12, 2018 Announcements “The biopharma industry in Massachusetts continues to bring value to the overall healthcare system and to patients, and is constantly looking for new ways to lower drug costs. [4]

That compares with $1.62 billion in investments for that same period for all of Massachusetts. [3]

The 2018 Industry Snapshot report ? noted that the proportion of biotech initial public offerings (IPOs) the state was responsible for had jumped from 30% in 2016 to close to half. [1] The industry’s success is also expanding across the Commonwealth, with half of the 2017 Massachusetts-based IPOs occurring in biotechs outside of Cambridge in places like Waltham, Newton and Burlington. [14]

With the economic climate of the last few years, both regions have faced some challenges, but the unique mix of features that have enabled the biotech industry sector to thrive in these areas is not easily replicated. [3] Both areas have established broad-based biotech industry segments that are growing. [3] Those numbers were drawn from professional, scientific, and technical services needed by the industry, which may include jobs not directly involved in bioscience or biotech. [3]

The rush to be part of the biotech hub has led to the rapid growth in lab space being developed in the area, with 29-square-feet of space being developed in the state – representing an increase of 71% over the course of a decade. [1] The prevalence of small biotech in and around San Francisco isn’t surprising for anyone familiar with the quantity of venture investment in this area. [3] It is not clear which is the top biotech cluster, but what is clear is that combined, Boston and San Francisco host high concentrations of biotech activity. [3] According to the San Francisco Center for Economic Development, by the end of 2016, the metropolitan area’s biotech sector employed 127,500 workers. [3]

“The money will continue to follow the science, and biotech startups will continue to grow throughout Massachusetts, spreading the wealth across the state,” predicted Robert K. Coughlin, president and CEO of MassBio, in a statement. [5] MassBio also reported that Massachusetts biotechs accounted for nearly half (48%) of all U.S.-based biotech initial public offerings (IPOs) last year, up from 30% in 2016. [5] Takeda’s merger with Shire was already expected to make the combined company the largest biotech employer in Massachusetts, combining Takeda’s 2,150 local employees with about 3,000 Shire employees. [6]

More than half of Massachusetts’ total biopharma jobs are in biotech R&D, which last year rose to 35,768 jobs, up 4.1% from 34,366 in 2016, the report stated. [5] Massachusetts’ growth in biotech R&D jobs was only about half that of California, which produced 17,954 such jobs between 2008 and 2017, up nearly 85%. [5]

The Golden State saw its R&D job growth zoom 15% year-over-year, to 39,203 jobs last year–catapulting California over Massachusetts to become the nation’s top state for biopharma R&D jobs. [5] The Bay State’s biopharma workforce grew 4.3% last year to a total 69,941 jobs, up from 67,046 in 2016, the Massachusetts Biotechnology Council (MassBio) reported in its Industry Snapshot 2018. [5] In biopharma manufacturing, MassBio said, Massachusetts last year recorded 10,072 jobs, down 1.9% from 10,264 in 2016, but still up 5.1% from 9,581 jobs in 2008. [5] The 2017 total represents a nearly 29% increase in Massachusetts biopharma jobs from the 54,280 reported in 2008, MassBio said. [5] MassBio recorded a record-high year in venture capital investment in Massachusetts last year of $3.1 billion, accounting for more than one-third (37%) of all U.S. biopharma VC dollars–compared with $2.9 billion recorded for 2016. [5] “Massachusetts biopharmas continue to lead the industry in tackling the toughest unmet medical needs, creating a new wave of breakthrough therapies that treat the underlying cause of disease, not just the symptoms, and some that people are even calling cures,” MassBIO President and CEO Robert Coughlin said. [2] The 2017 Massachusetts IPOs ranged from the approximately $132.4 million in net proceeds raised by Akcea Therapeutics–which ranked number 10 on GEN’s list of the Top 25 Biopharma IPOs of 2017 –to the approximately $39.5 million in net proceeds raised by Arsanis. [5] California also enjoyed the highest amount of, with 3,939 jobs created between 2006 and 2015, while Massachusetts ranked second with 2,672 jobs, the report added. [5] Massachusetts is on pace to surpass last year’s VC total in 2018, since $2.7 billion was invested between January-June 2018. [5]

Massachusetts’ biopharma manufacturing workforce was the nation’s 10 th largest. [5] Sanofi remains Massachusetts’ largest biopharma employer, though its workforce shrunk by 200 from MassBio’s Industry Snapshot 2017, to 4,800 employees. [5]

The BioTech market focuses on early stage BioTech, BioPharma and other Life Science product… provide VWR solutions to customers across the Pharmaceutical, Biotech, and Industrial & Production Technology markets. [15] Biotech giant Takeda Pharmaceutical Co. will move its U.S. headquarters to the Boston area from its current offices near Chicago, the company said, as it prepares to acquire Shire Plc in a deal expected to close next year. [6] Always a biotech mecca, the Boston area has added more and more biotech jobs in recent years. [6]

Rounding out the top five states in biotech R&D jobs last year were Maryland (15,351 jobs), Pennsylvania (13,413), and New Jersey (12,976). [5]

ViaCyte, a San Diego stem cell therapy biotech, has teamed up with a Massachusetts gene-editing company to take on diseases like diabetes. [16] Viking Therapeutics Inc. stock rocketed 140% in premarket trade Tuesday, after the company reported positive results in a mid-stage trial of a treatment for non-alcoholic fatty liver disease, or NAFLD. The San Diego-based biotech said the Phase 2 trial of VK2809, its novel liver-selective thyroid receptor beta agonist, in patients NAFLD and elevated low-density lipoprotein cholesterol met its primary goal of reducing LDL-C compared with placebo. [17]

North Carolina has eight of the top-20 biotech and pharmaceutical employers that are highlighted in the current issue of Science, the magazine published by the American Association for the Advancement of Science. [8]

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. [18] The winner of this year?s top spot, for the first time, is Vertex Pharmaceuticals, of Cambridge, Mass. Next came Regeneron Pharmaceuticals, of Tarrytown, N.Y., and Genentech, of South San Francisco. [8]

Mass Development has awarded $100,000 in matching manufacturing career grants to 12 Massachusetts partnerships, including three in Central Mass. receiving $28,000 total. [11] Brammer Bio, a best-in-class cell and gene therapy contract development and manufacturing organization, has been recognized by MassEcon for outstanding contributions to the Massachusetts economy. [11] Another top industry in Massachusetts stems from the biotechnology sector known as Biogen. It is an American multinational biotechnology company specializing in the discovery, development, and delivery of therapies for the treatment of conditions such as autoimmune diseases to patients worldwide. [12] Wave Life Sciences Ltd., a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced the public opening of its new 90,000 square foot state-of-the-art manufacturing facility and office space in Lexington, Massachusetts. [11] MassMEP, the Massachusetts Manufacturing Extension Partnership, is pleased to present the 2nd annual Jack Healy Manufacturing Leadership Award to North Easton Machine Company, Inc. North Easton is being recognized for their dedication to training and for building a skilled workforce. [11] Tegra Medical was honored as a products leader in the first annual Massachusetts Manufacturing Caucus Awards. [11] Interstate Electrical Services Corp. today introduced the first apprenticeship program in Massachusetts specifically designed for manufacturing assemblers. [11] Bay State Wind, the 50-50 partnership between Ørsted, the global leader in offshore wind, and Eversource, New England’s premier transmission builder, today announced it has entered into an agreement with EEW, the international market leader in steel pipe manufacturing, to open and staff a Massachusetts facility to manufacture offshore wind components. [11] Nashoba Valley Technical High School is one of 10 technical high schools in Massachusetts targeted for a new program through which Bay State residents interested in careers in advanced manufacturing can take classes and be eligible for state and federal financial aid to pay for their training. [11] Despite an average overall score, manufacturing in Massachusetts improved in several categories between 2016 and 2017, according to new data from Ball State University and Indiana’s advanced manufacturing initiative. [11] For the broader healthcare industry, the state percentage of total private jobs (16.1) is higher than the national average of 12.7 percent, and even higher than health-dense Massachusetts, at 15.7. [13] Employing a total of 109,226 workers, Massachusetts’ clean energy sector grew by 4% between 2016 and 2017, according to the new “Clean Energy Industry Report” from the Massachusetts Clean Energy Center (MassCEC). [11] A new report details how much it would cost to ready each of 18 Massachusetts sites for offshore wind manufacturing, staging, and operations. [11] Highlighting the precision manufacturing and other high-skills job opportunities that are going unfilled across Berkshire County and Western Massachusetts, U.S. Rep. Richard Neal, D-Springfield, stressed Tuesday that more must be done to connect local residents to these positions. [11] Another business on the fortune 500 lists located in Massachusetts is Raytheon; a primary U.S. defense contractor and the industrial corporation that concentrates on manufacturing weapons and military and commercial electronics. [12] An SBA loan is not a loan provided by the U.S. government, but instead loans that are originated by small banks, large banks, and community lending to Massachusetts small businesses, and the government agreed to cover most of their losses if the small business fails to repay. [12] If you are a Massachusetts small business owner in need of financing, and would like some help understanding and locating the best financing options, please reach-out to our funding specialists, and we’ll help you secure the best possible loan for your company. [12] There are multiple ways for a Massachusetts small business to finance their company equipment. [12] With factoring, the accounts receivable and invoices are sold to a factoring company who then forwards the Massachusetts small business portion of the invoices value until the invoice is fully-paid. [12] Lastly, one of the most prosperous business institutions founded in Massachusetts, State Street Corporation, or only referred to as State Street, is an American worldwide financial services company based in 1792–the second oldest financial institution in the United States. [12] This week the Baker-Polito Administration, in coordination with the Smaller Business Association of New England (SBANE), awarded $216,067 to 32 small and medium-sized manufacturers based in Massachusetts that will support more than 1,400 jobs across the Commonwealth. [11] Siemens is breaking ground in Massachusetts on Friday to build a diagnostics, manufacturing and engineering site that will create more than 1,000 new jobs. [11] The finalists, spanning Greater Boston to Western Massachusetts, range in size and are drawn from manufacturing, distribution, life sciences, food, robotics, entertainment, and software. [11] The award ceremony took place at the Massachusetts State House in Boston on October 26, 2016 with chairmen Senator Eric Lesser and Representative John Fernandes. [11] Welcome to the new Massachusetts industrial revolution, where workers, armed with computing power and automation, have made manufacturing a comeback story in the state. [11] Individuals can now state Massachusetts as one of the global leaders in biotechnology, engineering, higher education, finance, and maritime trade. [12] The Central Massachusetts Workforce Investment Board and the city of Worcester are one of five recipients of $200,000 in state grants to help increase internship opportunities in STEM fields for high school students. [11] Better: Little Rhody’s founder Roger Williams, fleeing religious persecution in 17th-century puritanical Massachusetts, was one of America’s first abolitionists and created the concept of the separation of church and state. [13] On March 16, 2018, Massachusetts joined a growing minority of states — California, Vermont and Illinois — recognizing innovator liability of name-brand drug manufacturers. [11] They’ve tried to have it doubled, to no avail. (Compare that to the $1 billion fund Massachusetts created in 2008 for its life science sector, recently renewed for another five years and $623 million.) [13] Takeda Pharmaceutical Co. Ltd. has agreed to acquire Shire plc for $62 billion, creating what will be the largest life sciences employer in Massachusetts with more than 5,000 employees, barring layoffs. [11]

The company known as Liberty Mutual remains to be a powerhouse in Massachusetts as it is one of the leading industries in the U.S. As an insurance company, they offer a wide range of products and services all geared towards helping people preserve and protect what they earn, build, and own. [12] Emergent BioSolutions Inc today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for the manufacture of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) in the company’s newly-acquired cGMP live viral manufacturing facility in Canton, Massachusetts. [11]

With their cutting-edge science and medicine, they continue to develop and deliver worldwide innovative therapies for people living with severe neurological and neurodegenerative diseases while simultaneously contributing to the robust Massachusetts economy. [12] SMi’s next annual conference in the global series of events on Pre-Filled Syringes will return to Boston, Massachusetts next April with Pre-Filled Syringes East Coast 2018. [11] The line of credit allows a Massachusetts small business to draw on funds without having to get further approval from the bank and interest only accrues on the money that?s used not the overall approval amount. [12] By using equipment leasing, Massachusetts small businesses are able to acquire vital business equipment without having to pay the full-cost of the equipment upfront. [12] Alternative business loans for Massachusetts small businesses require less personal and business documentation in order to qualify than conventional loans. [12] There are hundreds, if not thousands of financing options available to small and mid-sized Massachusetts small businesses. [12] A line of credit is a type of preapproved financing that allows Massachusetts small businesses to access financing whenever they need it. [12] Accounts receivable financing is a type of asset based financing that allows Massachusetts small businesses to obtain a line of credit by using their 0 to 90 days accounts receivable as collateral. [12] This is the perfect type of financing for Massachusetts small businesses that are in need of working capital but have a lag in payment from their customers. [12]

American textile maker Merida, which designs and weaves made-to-order rugs in Fall River, is a 2017 recipient of a Workplace Training Fund grant from the Massachusetts Executive Office of Labor and Workforce Development. [11] Massachusetts just created a new way to bulk up its advanced manufacturing workforce. [11] In celebration of National Manufacturing Day, the Baker-Polito Administration awarded $7 million in funding to support growth in seven innovative advanced manufacturing projects across the Commonwealth through the Massachusetts Manufacturing Innovation Initiative (M2I2). [11]

A Chinese biotech company will build a $60-million facility at the Worcester Biomanufacturing Park, becoming the first tenant at the site of the former Worcester State Hospital, which the Worcester Business Development Corp. is attempting to turn into a major biotechnology hub. [11] These charts show the average base salary (core compensation), as well as the average total compensation for the job of Business Development Director – Biotech in Boston, MA. The base salary for Business Development Director – Biotech ranges from $154,047 to $193,087 with the average base salary of $171,486. [19] The question, then, is what kind of jobs? Some civic leaders argue the state needs to capitalize on its academic strengths: design, engineering, and healthcare that feed a converging variety of disciplines, but not necessarily the traditional pharma-heavy R&D that has turned Boston into the world’s biotech epicenter. [13] While biotech has boomed in the Boston area just north and in other major clusters, Rhode Island’s biosciences community has shed 10 percent of its jobs since 2014, according to the BIO national trade organization. [13] The state commerce department says biotech provides the same percentage of private jobs statewide, just under 1 percent, as nationwide. [13]

North Shore InnoVentures (NSIV), a non-profit technology business incubator helping biotech and cleantech startups increase their probability of success, was presented with the Dinah Adkins Technology Incubator of the Year Award at this year’s International Business Innovation Association (InBIA) annual convention. [11]

RANKED SELECTED SOURCES(19 source documents arranged by frequency of occurrence in the above report)

1. (36) News & Events | Manufacturing in Massachusetts

2. (23) Massachusetts Business Loans: Financing For Bay State Small Businesses GUD Capital

3. (18) Massachusetts Biopharma Shows Workforce, Investment Growth | GEN

4. (12) Largest U.S. Biotech Hubs: Boston and the San Francisco Bay

5. (8) Biotech and pharma are big business for Lexington and for Mass. – News – Burlington Union – Burlington, MA

6. (7) Xconomy: In Bostons Shadow, Rhode Island Fights for Life Science Jobs, Respect

7. (6) Nearly half of investments into biotech industry generated by Massachusetts

8. (5) Massachusetts Biotechnology Council

9. (4) Biotech behemoth Takeda moving to Boston | Boston Herald

10. (3) N.C. Has 8 of Science Mags Top-20 Firms | North Carolina Biotechnology Center

11. (2) MassBio Industry Snapshot – Massachusetts Biotechnology Council

12. (2) Biotech bay

13. (1) ELISA and Kits Companies

14. (1) Biotech Consultant Jobs in Boston, MA | Glassdoor

15. (1) Biotechnology | San Diego Business Journal

16. (1) Biotech Industry – MarketWatch

17. (1) 3 Sanofi Genzyme Careers & Jobs – Zippia

18. (1) Salary for Business Development Director – Biotech in Boston, MA | Salary.com

19. (1) LaVoie Health Science – Boston Massachusetts